Edited by Wolfgang Peti ␣-Synuclein (␣S) is the primary protein associated with Parkinson's disease, and it undergoes aggregation from its intrinsically disordered monomeric form to a cross- fibrillar form. The closely related homolog -synuclein (S) is essentially fibril-resistant under cytoplasmic physiological conditions. Toxic gain-of-function by S has been linked to dysfunction, but the aggregation behavior of S under altered pH is not wellunderstood. In this work, we compare fibril formation of ␣S and S at pH 7.3 and mildly acidic pH 5.8, and we demonstrate that pH serves as an on/off switch for S fibrillation. Using ␣S/S domain-swapped chimera constructs and single residue substitutions in S, we localized the switch to acidic residues in the N-terminal and non-amyloid component domains of S. Computational models of S fibril structures indicate that key glutamate residues (Glu-31 and Glu-61) in these domains may be sites of pH-sensitive interactions, and variants E31A and E61A show dramatically altered pH sensitivity for fibril formation supporting the importance of these charged side chains in fibril formation of S. Our results demonstrate that relatively small changes in pH, which occur frequently in the cytoplasm and in secretory pathways, may induce the formation of S fibrils and suggest a complex role for S in synuclein cellular homeostasis and Parkinson's disease.
␣-Synuclein (␣S),5 the primary protein component of intracytoplasmic inclusions known as Lewy bodies (LB) in Parkinson's disease (PD), is a 140-residue, predominantly monomeric, intrinsically disordered protein (IDP) (1-6). It is abundant in the cytosol but present in many organelles (7,8). The monomers of ␣S can aggregate to soluble oligomers as well as insoluble oligomers and fibrils, which are considered to be associated with the pathogenesis of PD (9). A closely related family member, -synuclein (S) that co-localizes with ␣S, has ϳ60% sequence identity with ␣S but has not been detected in LBs of PD patients (10, 11). Instead, it has been proposed that S may delay ␣S fibril formation and ameliorate ␣S toxicity in vivo by inhibiting ␣S aggregation (12-14). Furthermore, despite the high sequence similarity, S itself does not form fibrils in vitro at cytoplasmic pH without facilitating agents (15). However, recent reports highlight a role for a possible toxic gain-of-function of S in two different model systems (16,17), and S is a component of vesicle-like lesions in the hippocampus, whose formation accompanies dementia in PD (18). In addition, two S mutations, V70M and P123H, were found in sporadic and familial dementia with LBs and have been suggested to be involved in lysosomal pathology (19 -21). There is an emerging role for S in the pathophysiology of PD, but the molecular determinants of this role remain poorly studied.Understanding the complex relationship of synucleins with neurodegeneration requires consideration of their structures and functions in diverse subcellular environments, beyond the cytoplasm. Altho...